clinical trial · NCT00140907
ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)
Organon and Co·phase4·completed·n = 367
High Blood Pressurelosartan potassiumComparator: Placebo
brief summary
To demonstrate that losartan (+ conventional therapy) compared to placebo (+ conventional therapy) will reduce the number of RT patients who experience histological lesions of chronic allograft nephropathy
started
Mar 14, 2000
primary completion
Jan 1, 2005
completion
Jan 1, 2005
last updated
Aug 15, 2024
official title
A Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Renal Transplant
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol